Figure 1

Human epidermal growth factor receptor 2 (HER2) expression in ovarian cancer (OC) stratified by various biomarkers. (A) Overall distribution of HER2 expression and that stratified by (B) BRCA, (C) mismatch repair (MMR), and (D) programmed cell death ligand 1 (PD-L1) status.